Cannabis-Induced Psychosis (CIP) Drug Pipeline Market Insights Report 2025 | In-Depth Analysis of CIP Therapeutics – From Early R&D to Market, Covering Collaborations, Licensing, and Clinical Trials
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. …
Dublin, July 25, 2025 (GLOBE NEWSWIRE) — The “Cannabis-Induced Psychosis (CIP) – Pipeline Insight, 2025” drug pipelines has been added to ResearchAndMarkets.com’s offering.
The report outlays compr…